Bill Ackman, Executive Chairman of Howard Hughes, called the acquisition "a milestone event in the transformation of Howard Hughes into a diversified holding company," saying that "In Vantage, HHH obtains an exceptional diversified specialty insurance and reinsurance platform managed by an excellent and highly experienced team." Vantage CEO Greg Hendrick said the deal represented "Vantage's next chapter," adding that with Howard Hughes' "permanent capital and long-term vision, we expect to strengthen our balance sheet and expand opportunities in specialty insurance, reinsurance, and partnership capital." HHH Chief Investment Officer Ryan Israel said the company structured the deal "to enable Howard Hughes to acquire 100% legal ownership of Vantage today, and over time to increase its economic ownership to 100% in what we expect to be a highly accretive manner."
The transaction was structured as a purchase of 100% of Vantage's outstanding capital stock by Howard Hughes Insurance Holdings, LLC, a wholly owned HHH subsidiary, from Vantage's founding institutional owners, Carlyle Partners VII Cayman Holdings V, L.P. and H&F Vantage Aggregator, L.P., along with other Vantage shareholders. The approximately $2.1 billion cash purchase price represented 1.5 times Vantage's estimated year-end 2025 book value and an implied approximately 1.4 times price-to-book-value multiple at closing. The agreement included a "locked box" mechanism under which HHH retained the benefit of any book value accretion at Vantage between signing and closing. At signing, HHH disclosed that if closing had not occurred by June 30, 2026 for reasons other than Vantage's or the sellers' breach, the purchase price would have increased by the average yield on the J.P. Morgan 100% U.S. Treasury Securities Money Market Fund from January 1, 2026 through closing; because closing occurred on June 4, 2026, before that date, no such increase applied.
The deal was funded with approximately $1.2 billion of cash on HHH's balance sheet and $1.0 billion from Pershing Square Holdings, Ltd. (PSH) in the form of non-voting, non-interest-bearing Exchangeable Perpetual Preferred Stock issued by HHH, pursuant to an equity commitment letter signed concurrently with the purchase agreement. The PSH Preferred ranks pari passu with HHH common stock, carries no liquidation preference, and is convertible into Vantage common stock if not redeemed by HHH within seven years of issuance. HHH holds a call option during a 60-to-90-day window after each of the first seven fiscal years to repurchase the preferred for cash equal to the greater of (i) the original issue price plus 4% per annum (compounded daily), or (ii) 1.5 times Vantage's book value multiplied by the preferred holders' as-exchanged ownership percentage; HHH has stated it expects to fully redeem the PSH Preferred and reach 100% economic ownership of Vantage well within that seven-year term. If HHH does not redeem it in full, PSH retains the right to cause a public listing of Vantage, and unpurchased shares would begin accruing a 10% annual "Defaulted Repurchase Dividend Rate." Pershing Square Capital Management, L.P. will act as investment manager of Vantage's general account and investment portfolios on a fee-free basis under HHH's existing services agreement with Pershing Square, with Vantage's portfolio to be repositioned over time into cash, short-term Treasurys, and common stocks.
According to the investor presentation, Vantage generated $1.2 billion of net premiums written over the trailing twelve months ended September 30, 2025 (approximately 60% specialty insurance, 40% reinsurance), held a book value of $1.3 billion as of that date, and carried an "A-" rating from both AM Best and S&P. On a trailing-twelve-month basis as of September 30, 2025, Vantage reported $1,601 million of gross written premium, a 97.1% combined ratio (61.4% loss ratio, 35.7% expense ratio), $150 million of pre-tax income, and a 13% pre-tax return on equity, with 370 employees. The company was founded in 2020 and has no legacy reserve issues. The purchase agreement and presentation do not disclose any cost-synergy dollar figure, phase-in schedule, or EPS accretion/dilution estimate for the transaction; instead, HHH's stated value-creation thesis rests on de-levering Vantage's balance sheet, repositioning its investment portfolio toward equities managed fee-free by Pershing Square, and improving underwriting profitability by removing pressure for premium growth.
Closing conditions disclosed in the agreement included receipt of insurance regulatory approvals in the United States and Bermuda, expiration or termination of the Hart-Scott-Rodino antitrust waiting period, continued accuracy of representations and warranties, performance of covenants, and the absence of a material adverse effect at Vantage. The filings reviewed do not disclose a specific termination fee dollar amount; the agreement instead described mutual termination rights tied to failure to close by December 17, 2026, failure of a closing condition, a burdensome regulatory condition, or uncured material breach. All conditions were satisfied, and the transaction closed on June 4, 2026, with HHH entering a Subscription Agreement with PSH for the $1.0 billion of Series A Non-Voting Exchangeable Perpetual Preferred Stock on terms consistent with the original equity commitment letter.